Total Payments
$11,741
2024 Payments
$1,765
Companies
44
Transactions
699
Medicare Patients
9,291
Medicare Billing
$810,303
Payment Breakdown by Category
Food & Beverage$11,640 (99.1%)
Education$100.77 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,640 | 693 | 99.1% |
| Education | $100.77 | 6 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,167 | 185 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,308 | 54 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,187 | 78 | $0 (2024) |
| GENZYME CORPORATION | $649.41 | 25 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $605.81 | 32 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $513.07 | 24 | $0 (2023) |
| Inspire Medical Systems, Inc. | $456.88 | 13 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $453.76 | 20 | $0 (2019) |
| Mylan Specialty L.P. | $432.75 | 28 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $337.75 | 15 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,765 | 71 | Inspire Medical Systems, Inc. ($325.40) |
| 2023 | $1,271 | 63 | GENZYME CORPORATION ($222.81) |
| 2022 | $1,503 | 79 | GENZYME CORPORATION ($235.59) |
| 2021 | $1,564 | 83 | GlaxoSmithKline, LLC. ($469.23) |
| 2020 | $1,302 | 78 | GlaxoSmithKline, LLC. ($264.50) |
| 2019 | $1,512 | 115 | GlaxoSmithKline, LLC. ($261.53) |
| 2018 | $1,082 | 94 | GlaxoSmithKline, LLC. ($196.17) |
| 2017 | $1,743 | 116 | AstraZeneca Pharmaceuticals LP ($305.89) |
All Payment Transactions
699 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $28.72 | General |
| Category: NEUROLOGY | ||||||
| 11/25/2024 | Itamar Medical Inc | WatchPATONE (Device) | Food and Beverage | Cash or cash equivalent | $175.69 | General |
| Category: Sleep Apnea testing | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $108.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: Pulmonology | ||||||
| 11/18/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $32.39 | General |
| Category: NEUROLOGY | ||||||
| 11/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Immunology | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.39 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $10.80 | General |
| Category: Narcoplepsy | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: Immunology | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: NEUROLOGY | ||||||
| 10/25/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: NEUROLOGY | ||||||
| 10/24/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $97.81 | General |
| Category: NEUROLOGY | ||||||
| 10/22/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Pulmonology | ||||||
| 10/21/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: NEUROLOGY | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $53.90 | General |
| Category: Pulmonology | ||||||
| 09/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,974 | 3,657 | $872,782 | $240,421 |
| 2022 | 23 | 2,355 | 3,104 | $679,068 | $192,326 |
| 2021 | 23 | 2,131 | 3,052 | $689,604 | $204,089 |
| 2020 | 23 | 1,831 | 2,585 | $583,808 | $173,467 |
Total Patients
9,291
Total Services
12,398
Medicare Billing
$810,303
Procedure Codes
116
All Medicare Procedures & Services
116 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 899 | 1,250 | $348,084 | $110,215 | 31.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 218 | 218 | $83,624 | $25,070 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 339 | 365 | $63,145 | $22,647 | 35.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 39 | 129 | $22,369 | $11,162 | 49.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 72 | 88 | $34,306 | $10,761 | 31.4% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 127 | 128 | $50,320 | $10,597 | 21.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 107 | 111 | $44,137 | $9,845 | 22.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 115 | 115 | $33,427 | $7,571 | 22.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 32 | 32 | $15,904 | $4,225 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 18 | 64 | $15,408 | $4,186 | 27.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 85 | 93 | $8,835 | $3,515 | 39.8% |
| 99183 | Management of oxygen chamber therapy | Facility | 2023 | 13 | 41 | $16,523 | $3,288 | 19.9% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2023 | 92 | 93 | $38,265 | $3,010 | 7.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 25 | $8,625 | $2,958 | 34.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 141 | 153 | $13,287 | $2,750 | 20.7% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 24 | 27 | $15,775 | $2,404 | 15.2% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 344 | 346 | $25,998 | $2,090 | 8.0% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Facility | 2023 | 39 | 39 | $6,500 | $1,059 | 16.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 15 | $1,925 | $901.20 | 46.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 59 | $3,304 | $579.04 | 17.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 16 | 16 | $3,616 | $437.28 | 12.1% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 45 | 45 | $3,703 | $296.56 | 8.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 31 | 31 | $6,076 | $225.91 | 3.7% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 20 | 23 | $4,025 | $207.24 | 5.1% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 22 | 22 | $2,200 | $200.20 | 9.1% |
About Dr. Joyce Wade-Hamme, M.D
Dr. Joyce Wade-Hamme, M.D is a Critical Care Medicine healthcare provider based in Flowood, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093819799.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joyce Wade-Hamme, M.D has received a total of $11,741 in payments from pharmaceutical and medical device companies, with $1,765 received in 2024. These payments were reported across 699 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($11,640).
As a Medicare-enrolled provider, Wade-Hamme has provided services to 9,291 Medicare beneficiaries, totaling 12,398 services with total Medicare billing of $810,303. Data is available for 4 years (2020–2023), covering 116 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Flowood, MS
- Active Since 09/12/2006
- Last Updated 05/16/2024
- Taxonomy Code 207RC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1093819799
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,481
- DUPIXENT (Biological) $935.36
- OFEV (Drug) $833.48
- ACTHAR (Biological) $791.51
- SYMBICORT (Drug) $521.20
- INSPIRE (Device) $456.88
- UPTRAVI (Drug) $385.95
- Prolastin-C Liquid (Biological) $325.20
- XYWAV (Drug) $314.16
- Santyl (Drug) $309.11
- BEVESPI AEROSPHERE (Drug) $262.54
- Adempas (Drug) $242.57
- BREO (Drug) $223.23
- WatchPATONE (Device) $220.01
- ANORO (Drug) $212.97
- LUNA (Device) $185.16
- Yupelri (Drug) $179.24
- Esbriet (Biological) $170.52
- (8874) inCourage (Device) $165.13
- BREZTRI (Drug) $161.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.